Double-blind Trial of Four Hypotensive Drugs (methyldopa and Three Sympatholytic Agents)

Overview

Journal Br Med J

Specialty General Medicine

Date 1967 Jun 3

PMID 6025595

Citations 3

Authors

V Vejlsgaard

M Christensen

E Clausen

Affiliations

Soon will be listed here.

Citing Articles

Some aspects of the long-term treatment of severe hypertension with methyldopa.

Hamilton M Postgrad Med J. 1968; 44(507):66-9.

PMID: 5639232 PMC: 2466477. DOI: 10.1136/pgmj.44.507.66.

Hypotensive drugs. I.

Br Med J. 1969; 2(5653):365-8.

PMID: 4388782 PMC: 1983272.

Drug-induced sexual dysfunction.

McWaine D, Procci W Med Toxicol Adverse Drug Exp. 1988; 3(4):289-306.

PMID: 3054427 DOI: 10.1007/BF03259941.

References

OATES J, SELIGMANN A, Clark M, Rousseau P, Lee R . The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents. N Engl J Med. 1965; 273(14):729-34. DOI: 10.1056/NEJM196509302731402. View

Cotton S, Montuschi E . Side-effects of guanoxan. Br Med J. 1966; 1(5478):51. PMC: 1845305. DOI: 10.1136/bmj.1.5478.51-a. View

Johnson P, KITCHIN A, LOWTHER C, Turner R . Treatment of hypertension with methyldopa. Br Med J. 1966; 1(5480):133-7. PMC: 1843337. DOI: 10.1136/bmj.1.5480.133. View

Breckenridge A, Dollery C . Combined action of methyldopa and bethanidine. Evidence for a synergistic effect. Lancet. 1966; 1(7446):1074-6. DOI: 10.1016/s0140-6736(66)91014-2. View

Prescott L, BUHS R, Beattie J, SPETH O, TRENNER N, Lasagna L . Combined clinical and metabolic study of the effects of alpha-methyldopa on hypertensive patients. Circulation. 1966; 34(2):308-21. DOI: 10.1161/01.cir.34.2.308. View

PAGE I, DUSTAN H . A new, potent antihypertensive drug: preliminary study of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (guanethidine). J Am Med Assoc. 1959; 170(11):1265-71. DOI: 10.1001/jama.1959.03010110013003. View

SANNERSTEDT R, KJELLBO H, Backlund H . [Guanethidine (Ismelin) in the treatment of arterial hypertension]. Nord Med. 1961; 66:1112-7. View

BAYLISS R, Harvey-Smith E . Methyldopa in the treatment of hypertension. Lancet. 1962; 1(7233):763-8. DOI: 10.1016/s0140-6736(62)91782-8. View

Daley D, Evans B . Another hypotensive agent--methyldopa. Br Med J. 1962; 2(5298):156-8. PMC: 1925375. DOI: 10.1136/bmj.2.5298.156. View

10.

GILLESPIE Jr L, OATES J, CROUT J, SJOERDSMA A . Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension. Circulation. 1962; 25:281-91. DOI: 10.1161/01.cir.25.2.281. View

11.

LOWTHER C, Turner R . GUANETHIDINE IN THE TREATMENT OF HYPERTENSION. Br Med J. 1963; 2(5360):776-81. PMC: 1872845. DOI: 10.1136/bmj.2.5360.776. View

12.

Luke R, Kennedy A . METHYLDOPA IN TREATMENT OF HYPERTENSION DUE TO CHRONIC RENAL DISEASE. Br Med J. 1964; 1(5374):27-30. PMC: 1813017. View

13.

Peart W, Macmahon M . CLINICAL TRIAL OF 2-GUANIDINOMETHYL (1,4) BENZODIOXAN (COMPOUND 1003). Br Med J. 1964; 1(5380):398-402. PMC: 1813365. DOI: 10.1136/bmj.1.5380.398. View

14.

Lawrie T, LORIMER A, McAlpine S, REINERT H . CLINICAL TRIAL AND PHARMACOLOGICAL STUDY OF COMPOUND 1029. ("VATENSOL"). Br Med J. 1964; 1(5380):402-6. PMC: 1813383. DOI: 10.1136/bmj.1.5380.402. View

15.

Montuschi E, LOVEL T . GUANOXAN IN HYPERTENSION. Lancet. 1964; 2(7373):1339-40. DOI: 10.1016/s0140-6736(64)91130-4. View

16.

OATES J, Gillespie L, UDENFRIEND S, SJOERDSMA A . Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine. Science. 1960; 131(3417):1890-1. DOI: 10.1126/science.131.3417.1890. View

17.

Maxwell R, Mull R, PLUMMER A . [2-Octahydro-1-azocinyl)-ethyl]-guanidine sulfate (CIBA 5864-SU), a new synthetic antithypertensive agents]. Experientia. 1959; 15:267. DOI: 10.1007/BF02158076. View

18.

Davey M, REINERT H . PHARMACOLOGY OF THE ANTIHYPERTENSIVE GUANOXAN. Br J Pharmacol Chemother. 1965; 24:29-48. PMC: 1704060. DOI: 10.1111/j.1476-5381.1965.tb02078.x. View

19.

CASS R, Kuntzman R, Brodie B . Norepinephrine depletion as a possible mechanism of action of guanethidine (SU 5864), a new hypotensive agent. Proc Soc Exp Biol Med. 1960; 103:871-2. DOI: 10.3181/00379727-103-25702. View

20.

Dollery C, Emslie-Smith D, McMichael J . Bretylium tosylate in the treatment of hypertension. Lancet. 1960; 1(7119):296-9. DOI: 10.1016/s0140-6736(60)90233-6. View